Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (PARP) in the treatment of cancer

Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (PARP) in the treatment of cancer

US Patent 10449200 · Granted Oct 22, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibition of thymine DNA glycosylase in the treatment of cancer2024
Inhibition of thymine DNA glycosylase in the treatment of cancer2021
Combinations to treat cancer2021
Combinations to treat cancer2020
Combination of DNA repair inhibition with bendamustine or gemcitabine in the tre2019
Combination of DNA repair inhibition with bendamustine or gemcitabine in the tre2019
Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (P2018
Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (P2018
Sensitization of cancer cells to DNA damage by inhibiting kinases essential for 2016
Combined inhibition of the vitamin D receptor and DNA replication in the treatme2016
Combined inhibition of the vitamin D receptor and DNA replication in the treatme2016
Systems and methods for diagnosing a predisposition to develop colon cancer2015